Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.
Clinical trial NCT00636116 · COMPLETED
Trial details
- NCT number
- NCT00636116
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.